Bio-Rad Laboratories Class B
BIO.B
4 hedge funds and large institutions have $4.21M invested in Bio-Rad Laboratories Class B in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
4% more capital invested
Capital invested by funds: $4.04M → $4.21M (+$172K)
0% less ownership
Funds ownership: 0.58% → 0.58% (-0%)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$28.7K |
| 2 |
Barclays
London,
United Kingdom
|
-$5K |
| 3 |
Citigroup
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $3.17M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $927K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $112K | -$28.7K | -202 | -20% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $1K | +$1.42K | +10 | New |
|
|
5
Barclays
London,
United Kingdom
| – | -$5K | -39 | Closed |
|
|
6
Citigroup
New York
| – | -$2K | -12 | Closed |
|
BIO.B Hedge Fund Activity: Q2 2016 in Review
4 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2016, worth a combined $4.21M — up 4.3% from $4.04M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BIO.B and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Bank of America, opening a new position worth an estimated $1.42K. The largest seller was UBS Group, cutting an estimated $28.7K.
- 4 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2016, down from 5 in Q1 2016.
- Funds reported $4.21M of Bio-Rad Laboratories Class B stock for Q2 2016, up 4.3% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q2 2016 and 2 closed out, a net change of -1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2016 was Bank of America, an estimated $1.42K added.
- The largest Bio-Rad Laboratories Class B seller in Q2 2016 was UBS Group, an estimated $28.7K sold.
Based on aggregated 13F filings for Q2 2016.